Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

6:20am EDT
Price Change (% chg)

Rs2.50 (+0.34%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for SUN.BO


Sun Pharmaceutical Industries Limited is an international specialty pharma company. The Company manufactures and markets pharmaceutical formulations as branded generics, as well as generics in India, the United states and several other markets across the world. The Company’s business is divided into four segments: US Generics,... (more)


Beta: 0.66
Market Cap (Mil.): Rs1,550,991.00
Shares Outstanding (Mil.): 2,071.16
Dividend: 2.50
Yield (%): 0.33


  SUN.BO Industry Sector
P/E (TTM): 48.26 35.48 35.85
EPS (TTM): 15.52 -- --
ROI: 20.83 18.97 18.25
ROE: 18.97 19.75 19.12
Search Stocks

India's Sun Pharma acquires U.S.-based Pharmalucence

MUMBAI, July 16 - Sun Pharmaceutical Industries Ltd, India's third-largest generic drugmaker by sales, said on Wednesday it had acquired U.S.-based Pharmalucence Inc, which has sterile injectable capacity and research capabilities.

15 Jul 2014

Indian shares edge higher; defensives surge

* BSE index gains 0.15 pct; NSE ends 0.21 pct higher * Century Textile rallies after investor Damani buys stake * Aban likely to launch up to $150 mln share sale on Friday - sources * Ranbaxy gets FDA approval for Novartis's Diovan generic By Abhishek Vishnoi MUMBAI, June 27 - Indian shares rose on Friday as defensive stocks such as Sun Pharmaceutical Industries and Ranbaxy Laboratories jumped on the U.S. regulator's approval for a key drug while IT stocks gained

27 Jun 2014

UPDATE 1-India's Ranbaxy posts loss after write-offs on US import bans

* Compares with analysts' forecast for 958.7 mln in profit

09 May 2014

India's Ranbaxy posts March-quarter loss on write-offs

MUMBAI, May 9 - Indian drugmaker Ranbaxy Laboratories Ltd, which has agreed to be acquired by rival Sun Pharmaceutical Industries Ltd for $3.2 billion, posted a surprise loss in the March quarter due to write-offs related to regulatory sanctions for poor manufacturing quality.

09 May 2014

UPDATE 1-Market Chatter-Corporate finance press digest

(Adds item on Freshpet LLC, El Pollo Loco Inc, Sun Pharmaceutical Industries Ltd, Go Daddy Group)

10 Apr 2014

India's Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.: sources

MUMBAI - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a $3.2 billion takeover of its loss-making rival by the year end, sources with direct knowledge of the matter said.

09 Apr 2014

Update-Moody's: Daiichi Sankyo Will Benefit from Sun Pharma's Acquisition of Ranbaxy

Sun Pharmaceutical Industries Ltd (Sun Pharma) & Ranbaxy Laboratories Ltd (Ranbaxy)

09 Apr 2014

Deals of the day- Mergers and acquisitions

April 7 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

07 Apr 2014

CORRECTED-India's Sun Pharma expects Ranbaxy business to be profitable in short term

(Corrects first and last paragraphs to say Dilip Shanghvi is managing director, not chairman of Sun Pharma)

07 Apr 2014

India's Ranbaxy slumps, Sun Pharma surges on $3.2-billion acquisition

MUMBAI - Shares in India's Ranbaxy Laboratories Ltd fell as much as 3.2 percent on profit-taking after Sun Pharmaceutical Industries Ltd said it will buy the company in a $3.2 billion all-share deal, creating the world's fifth-largest generic drug maker.

07 Apr 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Plunkett Research, Ltd.
Provider: BuySellSignals Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks